Premier Research
Morrisville, NC; global · United States
Key Differentiator
Dosed first patient in groundbreaking in vivo CAR gene therapy trial (INVISE, Oct 2024)
Core Services
Phase I-IV clinical trials; Cell & gene therapy expertise; Complex first-in-class programs; MedTech trials
Capabilities
Market Intelligence
Dosed first patient in groundbreaking in vivo CAR gene therapy trial (INVISE, Oct 2024).
Similar Companies
AGC Biologics
Bothell, WA (US HQ); Boulder, CO; Longmont, CO ·
Proprietary CHEF1® expression system
ARSI Canada Inc.
Mississauga, ON (Unit 16, 6800 Kitimat Rd) · Custom synthesis, analytical development, drug development
Mississauga CRO
Actylis (Montreal Operations)
Quebec ·
Global API and excipient supplier with Canadian manufacturing
Ajinomoto Bio-Pharma Services
San Diego, CA; Oss, Netherlands ·
Proprietary AJICAP™ site-specific ADC bioconjugation technology
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.